Endava downgraded on weak demand and execution risks

J.P. Morgan downgraded Endava to Underweight from Neutral and cut its December 2026 price target to $5 from $9 after another quarterly miss and a reduced full-year outlook. Q3 revenue was £179 million, below expectations and guidance, while adjusted EPS of £0.05 missed forecasts as margins fell on weaker utilization and higher AI investment. Fiscal 2026 revenue guidance was lowered to £722 million-£726 million from £736 million-£750 million, and adjusted EPS guidance was slashed to £0.45-£0.49 from £0.80-£0.86.

Analysis

The market is likely still underestimating how much of the margin reset is self-inflicted versus cyclical. Once utilization slips and implementation cycles lengthen, services firms can lose pricing power fast because the same revenue mix shifts from high-margin delivery to lower-visibility recovery work; that can keep gross margins depressed even after top-line growth stabilizes. The bigger second-order risk is that AI-related projects, while strategically important, are becoming a working-capital and execution drag rather than an immediate growth engine, so the business may be investing ahead of monetization for several quarters.

Competitively, this creates an opening for better-executing peers with stronger offshore leverage and more repeatable productized delivery. If clients remain cautious, vendors with sharper vertical specialization or more software-heavy revenue mix should gain share from firms still reliant on time-and-materials and large bespoke deals. The implication is that this is not just a one-company miss; it can pressure valuation multiples across the mid-cap IT services basket as investors re-rate away from "AI narrative" names toward names with visible bookings and conversion metrics.

The key catalyst path is time-based: the stock likely stays pressured over the next 1-3 quarters unless management can show consecutive beats and a clear inflection in bookings conversion. A near-term squeeze is possible if guidance simply stops deteriorating, but that would be a trading event, not a fundamental re-rating. Conversely, another miss would likely force a second leg down because the market is already pricing a slow recovery; the asymmetry is worse than the headline drawdown suggests.

The contrarian view is that the selloff may already discount a lot of bad news, so the better trade may be relative rather than outright short. If earnings are near a trough, a flat print with stable margins could support a bounce, but only if accompanied by evidence that AI contracts are shortening from pilot to rollout. Absent that, rallies are probably sellable because the burden of proof has shifted entirely to management execution.

Key Decisions for Investors

• Short DAVA on any post-earnings relief rally; prefer a 1-3 month horizon with a tight stop above the recent pre-miss consolidation, targeting a re-test of lows if guidance or bookings deteriorate again.
• For event-driven downside with defined risk, buy DAVA put spreads 2-4 months out; the best setup is after a modest bounce, since implied volatility should compress unless there is a new warning.
• Pair trade: long stronger-execution IT services names vs short DAVA over the next 1-2 quarters. Favor names with higher recurring revenue and clearer bookings visibility; the trade should work if investors keep penalizing uncertainty and delivery slippage.
• Avoid bottom-fishing until there are at least 2 consecutive quarters of stable margins and conversion metrics. If management can demonstrate this, DAVA could become a tactical long, but not before.
• Watch for a catalyst shift in AI delivery economics; if outcome-based contracts begin to convert faster, cover shorts quickly because the stock can re-rate sharply from deeply depressed expectations.